Quantcast

SLIDESHOW

ACG New York Women of Leadership - Entrepreneur Series
Barbara Bradley Baekgaard, founder of Vera Bradley (Nasdaq: VRA), is the latest in a series of entrepreneurs highlighted at ACG New York Women of Leadership events. Photo credit: Robert Blumenfeld

Watercooler

GTCR, Hormel, the Riverside Co-CEOs and Others Win M&A Mid-Market Awards
Amid a slow and challenging year for dealmaking, the winners of Mergers & Acquisitions’ 7th Annual M&A Mid-Market Awards outpaced the competition to grow, innovate and lead the middle market

Roundtable

Financial Services Companies Heat Up M&A Market
Speakers from Flexpoint Ford, Genstar Capital, Baird Capital, Madison Capital Funding and Katten Muchin Rosenman discuss the various factors playing a role in M&A activity within the financial services space

Expert's Corner

Pursuing Pharma Manufacturing
The fragmented pharmaceutical manufacturing industry provides plenty of opportunities for private equity investors, says JLL Partners founder Paul Levy

Today's Transactions:
Pfizer Closes on NextWave Purchase, Could Pay Up to $700M

The deal gives Pfizer the rights to a liquid extended-release ADHD medication, Quillivant XR

New York pharmaceutical company Pfizer Inc. (NYSE: PFE) has completed its purchase of specialty pharmaceutical company, NextWave Pharmaceuticals Inc. for as much as $700 million.

NextWave develops and commercializes products, including Quillivant XR, that treat attention deficit hyperactivity disorder.

The price includes a $255 million payment to shareholders, plus $425 in potential additional payments based on sales milestones.

The deal was announced Oct. 22

 

For more information on related topics, visit the following: